Tesla Q1 Preview: Street Split on $25 to $600 Range
Tesla reports Wednesday with Wall Street's price targets spanning from $25 to $600. The real focus isn't EPS—it's Terafab capex guidance.
Wall Street can't agree on what Tesla is worth. Price targets range from $25 to $600—a 24x spread that reflects fundamentally different views of what the company actually is.
Tesla reports Q1 2026 results Wednesday after the close. The numbers will matter less than the narrative.
The Consensus Numbers
Analysts expect revenue of $21.9 billion to $22.7 billion, representing roughly 13% year-over-year growth. EPS estimates cluster around $0.36-$0.37, though Refinitiv's Smart Estimate sits lower at $0.30.
Deliveries already disappointed. Tesla shipped 358,023 vehicles in Q1, missing the 372,000 consensus by 4%. The stock has recovered from its initial reaction, but the delivery miss set expectations that margins will compress.
| Metric | Street Estimate | YoY Change |
|---|---|---|
| Revenue | $21.9B-$22.7B | +13% |
| EPS | $0.36-$0.37 | +33% |
| Deliveries | 358,023 (actual) | -3% miss |
Why the Street Is Split
The bull case: Tesla isn't a car company. It's an AI infrastructure play with an automotive business attached. Robotaxis. Optimus robots. Energy storage. The automotive segment is table stakes—the real upside comes from software and autonomy.
The bear case: Tesla is a car company with declining market share, aging products, and margin compression. The FSD revenue recognition is aggressive. Robotaxis remain a promise. And the CEO is increasingly distracted by politics and other ventures.
Both narratives can find support in the same earnings report. That's why the stock trades at 80x forward earnings while analysts argue about whether it should be $25 or $600.
The Terafab Question
The most important number Wednesday won't be in the press release. It's the capex guidance on the call.
Tesla's 2026 capital expenditure guidance already exceeds $20 billion—a significant jump from 2025. But that figure explicitly excludes Terafab, the company's planned one-terawatt AI compute facility.
If Terafab proceeds at full scale, analysts estimate the project could cost mid-single-digit trillions over time. That's not a typo. Trillions. It would represent a fundamental shift in how to value Tesla—transforming it from an automaker into an AI infrastructure company.
The Street wants clarity on timing, phasing, and financing. Elon Musk has been vague. Wednesday's call may provide the first real details.
Technical Setup
Tesla broke its eight-week losing streak last week, rallying with the broader market. The stock trades around $265, well below its 52-week high of $488 but up from the February lows near $180.
The chart shows a potential double bottom if support at $240 holds. But the fundamental story will dominate the technical picture—Q1 results will either validate the AI infrastructure thesis or reinforce the car company narrative.
What to Watch
Three questions matter Wednesday:
-
Gross margins: Automotive gross margins have compressed for five consecutive quarters. Has the bleeding stopped?
-
Terafab capex: Any concrete numbers or timelines shift the bull/bear debate.
-
FSD take rate: Full Self-Driving subscription and one-time purchase numbers indicate whether the software bet is working.
The delivery miss is priced in. What isn't priced in is whether Tesla's transformation from car company to AI platform is real—or just another Musk promise.